These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31254178)

  • 1. Effects of UGT1A1 Polymorphism, Gender and Triglyceride on the Pharmacokinetics of Telmisartan in Chinese Patients with Hypertension: A Population Pharmacokinetic Analysis.
    Huang L; Yang L; Huang J; Tan HY; Liu SK; Guo CX; Zuo XC; Yang GP; Pei Q
    Eur J Drug Metab Pharmacokinet; 2019 Dec; 44(6):797-806. PubMed ID: 31254178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of genetic variants in UGT1A1, SLCO1B3, ABCB1, ABCC2, ABCG2, ORM1 on PK/PD of telmisartan in Chinese patients with mild to moderate essential hypertension
.
    Pei Q; Yang L; Tan HY; Liu SK; Liu Y; Huang L; Li RH; Wan Q; Huang J; Guo CX; Zuo XC; Li J; Yang GP
    Int J Clin Pharmacol Ther; 2017 Aug; 55(8):659-665. PubMed ID: 28518053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacogenomic profiles of telmisartan after the oral microdose and therapeutic dose.
    Ieiri I; Nishimura C; Maeda K; Sasaki T; Kimura M; Chiyoda T; Hirota T; Irie S; Shimizu H; Noguchi T; Yoshida K; Sugiyama Y
    Pharmacogenet Genomics; 2011 Aug; 21(8):495-505. PubMed ID: 21691256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCB1 polymorphism and gender affect the pharmacokinetics of amlodipine in Chinese patients with essential hypertension: a population analysis.
    Zuo XC; Zhang WL; Yuan H; Barrett JS; Hua Y; Huang ZJ; Zhou HH; Pei Q; Guo CX; Wang JL; Yang GP
    Drug Metab Pharmacokinet; 2014; 29(4):305-11. PubMed ID: 24522199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of pharmacogenetics of metabolic enzymes and transporters on the pharmacokinetics of telmisartan in healthy volunteers.
    Yamada A; Maeda K; Ishiguro N; Tsuda Y; Igarashi T; Ebner T; Roth W; Ikushiro S; Sugiyama Y
    Pharmacogenet Genomics; 2011 Sep; 21(9):523-30. PubMed ID: 21829131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UGT1A3 and Sex Are Major Determinants of Telmisartan Pharmacokinetics-A Comprehensive Pharmacogenomic Study.
    Hirvensalo P; Tornio A; Launiainen T; Paile-Hyvärinen M; Tapaninen T; Neuvonen M; Backman JT; Niemi M
    Clin Pharmacol Ther; 2020 Oct; 108(4):885-895. PubMed ID: 32498119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No effect of MDR1 C3435T polymorphism on oral pharmacokinetics of telmisartan in 19 healthy Chinese male subjects.
    Guo X; Chen XP; Cheng ZN; Luo X; Guo R; Chen L; Chen J; Chen B; Peng J; Li YJ
    Clin Chem Lab Med; 2009; 47(1):38-43. PubMed ID: 19072027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of the angiotensin II type 1 receptor gene affect antihypertensive response to angiotensin receptor blockers in hypertensive Chinese.
    Gong HT; Ma XL; Chen BX; Xu XY; Li Q; Guo CX; Du FH
    Genet Mol Res; 2013 Jun; 12(2):2068-75. PubMed ID: 23913386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic Interaction Among Telmisartan, Amlodipine, and Hydrochlorothiazide After a Single Oral Administration in Healthy Male Subjects.
    Moon SJ; Jeon JY; Yu KS; Kim MG
    Clin Ther; 2019 Nov; 41(11):2273-2282. PubMed ID: 31564513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of polymorphisms of
    Gong H; Mu L; Zhang T; Xu X; Du F
    J Genet; 2019 Mar; 98():. PubMed ID: 30945668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Genetic Polymorphisms on the Pharmacokinetics of Deferasirox in Healthy Chinese Subjects and an Artificial Neural Networks Model for Pharmacokinetic Prediction.
    Chen J; Xu Y; Lou H; Jiang B; Shao R; Yang D; Hu Y; Ruan Z
    Eur J Drug Metab Pharmacokinet; 2020 Dec; 45(6):761-770. PubMed ID: 32930952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of mononucleotide polymorphisms of angiotensinogen gene at promoter region with antihypertensive response to angiotensin receptor blockers in hypertensive Chinese.
    Gong HT; Mu LY; Zhang T; Xu XY; Du FH
    J Renin Angiotensin Aldosterone Syst; 2019; 20(1):1470320319827205. PubMed ID: 30798697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan pharmacokinetics in Japanese renal transplant recipients.
    Miura M; Satoh S; Inoue K; Saito M; Habuchi T; Suzuki T
    Clin Chim Acta; 2009 Jan; 399(1-2):83-7. PubMed ID: 18838068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetic Modeling of Diltiazem in Chinese Renal Transplant Recipients.
    Guan XF; Li DY; Yin WJ; Ding JJ; Zhou LY; Wang JL; Ma RR; Zuo XC
    Eur J Drug Metab Pharmacokinet; 2018 Feb; 43(1):55-62. PubMed ID: 28646274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic comparison of an angiotensin II receptor antagonist, telmisartan, in Japanese and western hypertensive patients using population pharmacokinetic method.
    Tatami S; Yamamura N; Sarashina A; Yong CL; Igarashi T; Tanigawara Y
    Drug Metab Pharmacokinet; 2004 Feb; 19(1):15-23. PubMed ID: 15499165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between human atrial natriuretic peptide Val7Met polymorphism and baseline blood pressure, plasma trough irbesartan concentrations, and the antihypertensive efficacy of irbesartan in rural Chinese patients with essential hypertension.
    Zhang S; Mao G; Zhang Y; Tang G; Wen Y; Hong X; Jiang S; Yu Y; Xu X
    Clin Ther; 2005 Nov; 27(11):1774-84. PubMed ID: 16368448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.
    Israili ZH
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S73-86. PubMed ID: 10854085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactive Effect of the KCNJ11 Ile337Val Polymorphism and Cigarette Smoking on the Antihypertensive Response to Irbesartan in Chinese Hypertensive Patients.
    Jiang S; Venners SA; Hsu YH; Weinstock J; Wang B; Xing H; Wang X; Xu X
    Am J Hypertens; 2016 May; 29(5):553-9. PubMed ID: 26304961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment plasma renin activity levels correlate with the blood pressure response to telmisartan in essential hypertension.
    Minami J; Ishimitsu T; Matsuoka H
    Am J Hypertens; 2008 Jan; 21(1):10-3. PubMed ID: 18091737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic-pharmacodynamic modeling of telmisartan using an indirect response model in spontaneously hypertensive rats.
    Hao K; Chen YC; Cao YG; Yu D; Liu XQ; Wang GJ
    Acta Pharmacol Sin; 2007 May; 28(5):738-43. PubMed ID: 17439731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.